HEMOGLOBIN - ANVISA Registration 81175310091

Access comprehensive regulatory information for HEMOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81175310091 and manufactured by NOVA BIOMEDICAL CORPORATION. The registration is held by NOVA BIOMEDICAL DIAGNÓSTICOS MÉDICOS E BIOTECNOLOGIA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ACON LABORATORIES, INC., NOVA BIOMEDICAL CORPORATION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81175310091
Registration Details
ANVISA Registration Number: 81175310091
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

StatStrip® Hemoglobin and Hematocrit Linearity Solution Level 1, 2 and 3
Risk Class II

Registration Details

81175310091

25351094987201984

18271934000123

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 22, 2019

VIGENTE

09/18/2025 19:00:01